Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fluvoxamine

Next Previous
X
Search
Drug Profile

Fluvoxamine

Alternative Names: Depromel; Fluvoxamine maleate; Luvox; Luvox CR; SME-3110

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Solvay Pharmaceuticals
  • Developer Abbott Laboratories; AbbVie; Jazz Pharmaceuticals plc; Meiji Seika Pharma
  • Class Antidepressants; Oximes; Small molecules
  • Mechanism of Action Serotonin uptake inhibitors; Sigma-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Obsessive-compulsive disorders; Social phobia

Most Recent Events

  • 03 Jul 2017 Registered for Obsessive-compulsive disorders (In adolescents, In children) in Japan (PO) (Meiji Seika Pharma pipeline, August 2017)
  • 01 Aug 2016 AbbVie completes phase-III clinical trials in Obsessive-compulsive disorders (In adolescents; In children) in Japan (PO)
  • 19 Jan 2015 Fluvoxamine is still in phase III trials for Obsessive-compulsive disorders (in paediatric patients) in Japan

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top